San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Local Biotech Diagnostics Co. Signs Agreement With Big PPO

San Diego-based bioTheranostics Inc., a provider of genomic cancer diagnostic solutions, said it signed a contract with FedMed Inc., based in Maryland and one of the largest preferred provider organizations in the nation.

MabVax and Telik Complete Merger

San Diego-based MabVax Therapeutics Inc., a privately held cancer immunotherapy company, and Telik Inc., a publicly traded clinical-stage oncology drug development company, have finalized their merger.

Beetham Appointed CEO at Cibus

Peter Beetham has taken the CEO’s job at Cibus, the Mira Mesa-based biotech announced July 8.

Tease photo

HCP Buys Torrey Pines Life Science Property for $43.7M

Property was 93 percent occupied when it was sold.

GlassesOff Secures Commitment for Equity Financing of up to $15M

Financing could help fund global marketing.

Tease photo

Conatus Pharmaceuticals Moving Headquarters

Move comes after one year of being a public company.

Poway Company Gets FDA Approval to Market Assay for Iron Deficiencies

Diazyme Laboratories is part of General Atomics.

Cidara Completes $32M Financing

Biopharmaceutical company Cidara Therapeutics Inc. completed a $32 million Series A financing round, the company said.

Seragon Being Purchased in Deal Potentially Worth $1.7 Billion

Seragon Pharmaceuticals, a privately held San Diego-based drug developer targeting breast cancer treatment, agreed to be acquired by Genentech, a subsidiary of the Roche Group, for $725 million in cash plus future payments which could reach $1 billion if specific milestones are reached, the companies announced.

Tease photo

Scripps Opens Critical Care Pavilion as Part of $94M Expansion in Encinitas

Scripps Health announced the opening of the Leichtag Foundation Critical Care Pavilion, which includes a new emergency department and inpatient rooms at Scripps Memorial Hospital Encinitas.

Trovagene Secures Debt Facility of $15 Million

Trovagene Inc., a San Diego molecular diagnostics company, said it secured an unrestricted debt facility of $15 million from Silicon Valley bank and Oxford Finance LLC.

Cidara Therapeutics Completes $32M Series A Financing Round

Cidara Therapeutics, a privately held bio-pharmaceutical company formerly known as K2 Therapeutics, said it completed a $32 million Series A financing round.

Ambrx Withdraws IPO

La Jolla-based biotech Ambrx Inc. withdrew its plans for an initial public offering, citing current market conditions, according to Renaissance Capital.

Tease photo

Palomar Health Names Hemker as New CEO, President

Palomar Health has named Robert Hemker as its new president and chief executive officer.

S.D. Life Science Cluster Healthy

San Diego ranks third among U.S. cities for the economic health of its life sciences cluster, scoring high in a newly issued report on factors including research facilities, funding access and critical mass of startup and midtier companies.